EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹16 Cr | ₹-3.10 Cr | ₹-2.64 Cr | ₹2.07 Cr | ₹-2.05 Cr |
What is the latest Cash Flow from Financing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹-3.10 Cr |
| Mar2023 | ₹-2.64 Cr |
| Mar2022 | ₹2.07 Cr |
| Mar2021 | ₹-2.05 Cr |
How is Cash Flow from Financing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | Positive | |
| Mar2024 | ₹-3.10 Cr | Negative | |
| Mar2023 | ₹-2.64 Cr | Negative | |
| Mar2022 | ₹2.07 Cr | Positive | |
| Mar2021 | ₹-2.05 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹255.3 Cr | -2% | 17% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -2% |
17% |
-17.2% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses